Document is current
Any future updates will be listed below
-
Authors
Gaspar-Pérez, Anahí https://orcid.org/0000-0002-1427-3697
Paslakis, Georgios https://orcid.org/0000-0002-2069-0024
Rosinska, Magda https://orcid.org/0009-0009-9918-7592
Munguía, Lucero https://orcid.org/0000-0002-9751-810X
Jiménez-Murcia, Susana https://orcid.org/0000-0002-3596-8033
Szilágyi, Anna https://orcid.org/0009-0004-6242-1633
Miranda-Olivos, Romina https://orcid.org/0000-0003-2360-5830
Camacho-Barcia, Lucia https://orcid.org/0000-0002-5989-936X
Reque, Cristina Ballero https://orcid.org/0000-0003-0097-7594
Pászthy, Bea https://orcid.org/0000-0002-8009-3811
Fernández-Aranda, Fernando https://orcid.org/0000-0002-2968-9898
-
Funding
Funding for this research was provided by:
Plan Nacional sobre Drogas (2021I031)
Ministerio de Ciencia e Innovación (PDI2021-124887OB-I00)
Instituto de Salud Carlos III (FIS PI20/00132)
European Regional Development Fund (FIS PI20/00132)
Catalan Agency for the Management of Grants for University (2020 FISDU 00579)
Sara Borrell fellowship (CD22/00171)
Universitat de Barcelona
- License Information
-
More Information
Article History
Accepted: 8 August 2023
First Online: 16 September 2023
Declarations
:
: The present article is a systematic review of the literature and no studies with human participants or animals were performed by any of the authors to conduct this work.
: FFA and SJM received consultancy honoraria from Novo Nordisk and FFA editorial honoraria as EIC from Wiley. The rest of the authors declare no conflict of interest.
